Xiao-Dong Mo Selected Research

Residual Neoplasm

1/2022	Preemptive Interferon-α Therapy Could Protect Against Relapse and Improve Survival of Acute Myeloid Leukemia Patients After Allogeneic Hematopoietic Stem Cell Transplantation: Long-Term Results of Two Registry Studies.
12/2021	A risk score system for stratifying the risk of relapse in B cell acute lymphocytic leukemia patients after allogenic stem cell transplantation.
5/2021	Minimal residual disease monitoring and preemptive immunotherapies for frequent 11q23 rearranged acute leukemia after allogeneic hematopoietic stem cell transplantation.
3/2021	Wilms' tumor gene 1 is an independent prognostic factor for pediatric acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation.
1/2021	Dynamic immune profiling identifies the stronger graft-versus-leukemia (GVL) effects with haploidentical allografts compared to HLA-matched stem cell transplantation.
1/2021	Preemptive Immunotherapy for Minimal Residual Disease in Patients With t(8;21) Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation.
1/2020	Corrigendum to 'Interferon α: A potentially effective treatment for minimal residual disease in acute leukemia/myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation' [Biology of Blood and Marrow Transplantation 21/11 (2015) 1939-1947].
1/2020	Corrigendum to 'Interferon-α is effective for treatment of minimal residual disease in patients with acute leukemia after allogeneic hematopoietic stem cell transplantation: results of a registry study' [Biology of Blood and Marrow Transplantation 23/8 (2017) 1303-1310].
3/2019	Correction to: Minimal residual disease- and graft-vs.-host disease-guided multiple consolidation chemotherapy and donor lymphocyte infusion prevent second acute leukemia relapse after allotransplant.
1/2019	The significance of peri-transplantation minimal residual disease assessed by multiparameter flow cytometry on outcomes for adult AML patients receiving haploidentical allografts.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiao-Dong Mo Research Topics

Disease

25	Residual Neoplasm 01/2022 - 11/2015
21	Leukemia 05/2022 - 12/2014
17	Graft vs Host Disease (Graft-Versus-Host Disease) 05/2022 - 12/2009
15	Infections 01/2022 - 01/2016
14	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 01/2016
9	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2021 - 04/2015
8	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2020 - 11/2015
7	Aplastic Anemia (Anemia, Hypoplastic) 01/2022 - 01/2019
5	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 05/2013
5	Bronchiolitis Obliterans Syndrome 01/2022 - 05/2013
4	Thrombocytopenia (Thrombopenia) 12/2021 - 08/2014
3	Hemorrhage 01/2022 - 01/2013
3	Thrombotic Microangiopathies 01/2022 - 02/2018
3	Neoplasms (Cancer) 12/2020 - 01/2020
3	Hematologic Diseases (Blood Diseases) 11/2020 - 01/2019
2	Cytomegalovirus Infections (Inclusion Disease) 01/2022 - 01/2022
2	Pneumonia (Pneumonitis) 10/2021 - 11/2020
2	Disease Progression 01/2021 - 01/2019
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 11/2020 - 12/2015
2	Philadelphia Chromosome 01/2020 - 04/2015
2	Thrombosis (Thrombus) 08/2016 - 05/2015
1	Anemia 12/2021
1	Proteinuria 12/2021
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 06/2021
1	Oligospermia (Oligozoospermia) 04/2021
1	Asthenozoospermia 04/2021
1	Fanconi Anemia (Fanconi's Anemia) 01/2021
1	Acute Cholecystitis 01/2021
1	Ischemic Stroke 11/2020
1	Stroke (Strokes) 11/2020
1	Retinitis 11/2020
1	Gastroenteritis 11/2020
1	Encephalitis (Encephalitis, Rasmussen) 11/2020
1	Venous Thromboembolism 10/2020
1	Posterior Leukoencephalopathy Syndrome 10/2020
1	Pancytopenia 03/2020
1	Pancreatitis 01/2020
1	Tuberculosis (Tuberculoses) 01/2020
1	Cytomegalovirus Retinitis 01/2020
1	Cardiotoxicity 10/2019
1	Hepatitis 01/2019
1	Polyneuropathies (Polyneuropathy) 01/2019
1	Acute Promyelocytic Leukemia 01/2019
1	Guillain-Barre Syndrome 01/2019
1	Mucositis 11/2018
1	Sepsis (Septicemia) 11/2018
1	Demyelinating Diseases (Demyelinating Disease) 08/2018

Drug/Important Bio-Agent (IBA)

8	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 05/2013
7	InterferonsIBA 01/2022 - 11/2015
4	SteroidsIBA 01/2022 - 01/2019
4	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 01/2016
3	Basiliximab FDA Link 01/2022 - 01/2020
3	Prostaglandins FIBA 03/2020 - 01/2018
3	Immunoglobulin G (IgG)IBA 01/2019 - 08/2018
2	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2022
2	BilirubinIBA 01/2022 - 12/2021
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 01/2013
2	AntibodiesIBA 11/2020 - 01/2019
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2019 - 08/2017
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2019 - 03/2016
1	astaxanthine (astaxanthin)IBA 04/2021
1	Carnitine (L-Carnitine)FDA LinkGeneric 04/2021
1	inolimomabIBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2021
1	CytokinesIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	ruxolitinibIBA 01/2021
1	Chimeric Antigen ReceptorsIBA 12/2020
1	Valproic Acid (Depakote)FDA LinkGeneric 11/2020
1	Pamidronate (Aredia)FDA LinkGeneric 11/2020
1	Diphosphonates (Bisphosphonates)IBA 11/2020
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2020
1	Methylprednisolone FDA LinkGeneric 01/2019
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2019
1	GlucocorticoidsIBA 01/2019
1	HLA-A Antigens (HLA-A)IBA 01/2019
1	HLA-B Antigens (HLA-B)IBA 01/2019
1	Biological ProductsIBA 01/2019
1	Carbapenems (Carbapenem Antibiotics)IBA 11/2018
1	Interferon-alpha (Interferon Alfa)IBA 11/2018
1	Myelin-Oligodendrocyte GlycoproteinIBA 08/2018

Therapy/Procedure

66	Hematopoietic Stem Cell Transplantation 05/2022 - 01/2013
25	Transplantation 01/2022 - 05/2013
15	Therapeutics 01/2022 - 01/2013
14	Stem Cell Transplantation 01/2022 - 01/2016
8	Drug Therapy (Chemotherapy) 11/2020 - 05/2013
6	Haploidentical Transplantation 01/2021 - 01/2016
4	Immunotherapy 05/2021 - 08/2016
3	Cell Transplantation 01/2020 - 01/2016
2	Aftercare (After-Treatment) 01/2021 - 11/2018
2	Consolidation Chemotherapy 03/2019 - 01/2016
2	Induction Chemotherapy 12/2016 - 01/2016
1	Homologous Transplantation 01/2022
1	Plasma Exchange 01/2022
1	Salvage Therapy 01/2021
1	Total Parenteral Nutrition 01/2021
1	Platelet Transfusion (Blood Platelet Transfusions) 11/2020
1	Donor Selection 11/2020